January 30, 2019
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
Read More
December 10, 2018
Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
Read More
December 10, 2018
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Read More
Load More
X